A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19
Clinical Trial Grant
Administered By
Emergency Medicine
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 21, 2020
End Date
March 31, 2026
Administered By
Emergency Medicine
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 21, 2020
End Date
March 31, 2026